Effects of Vitamin D and Omega-3 Supplementation on Telomeres in VITAL

Status unconfirmed · Phase 3 · Has a placebo group

Conditions studied: Aging

In brief

The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) was a randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or fish oil (1 gram of omega-3 fatty acids) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. This ancillary study is being conducted among participants in VITAL-CTSC cohort and will examine whether vitamin D or fish oil supplementation has beneficial effects on cellular aging.

Key facts

Study ID

NCT04386577

Run by

Augusta University

People needed

1054

Starts

2016-08-19

Expected to finish

2021-04-30

Last updated by the study team

2020-05-13

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The subcohort of 1,054 participants in VITAL (NCT 01169259) who are receiving detailed health assessments at a Clinical and Translation Science Center at Boston are eligible to participate in this ancillary study:
• Exclusion Criteria: None

Where it is running

• Georgia Prevention Institute — Augusta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.